ID: ALA303545

Max Phase: Preclinical

Molecular Formula: C6H13NO3

Molecular Weight: 147.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC[C@H]1NCC[C@@H](O)C1O

Standard InChI:  InChI=1S/C6H13NO3/c8-3-4-6(10)5(9)1-2-7-4/h4-10H,1-3H2/t4-,5-,6?/m1/s1

Standard InChI Key:  YZNNBIPIQWYLDM-QYRBDRAASA-N

Associated Targets(non-human)

Alpha-mannosidase 2C1 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 147.17Molecular Weight (Monoisotopic): 147.0895AlogP: -1.94#Rotatable Bonds: 1
Polar Surface Area: 72.72Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.43CX Basic pKa: 8.63CX LogP: -2.20CX LogD: -3.45
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.35Np Likeness Score: 2.96

References

1. Winkler DA, Holan G..  (1989)  Design of potential anti-HIV agents. 1. Mannosidase inhibitors.,  32  (9): [PMID:2504921] [10.1021/jm00129a011]

Source